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ABSTRACT. Strum lipoprotein(a) (Lp( a)) and its correlates were studied in African Aboriginal Pygmies 
(n = 146) and Bantus (n = 208) f rom Cameroon. Geometric mean Lp(a) levels were 274 and 289 mg/l in 
Bantu males and females, respectively, and 220 and 299 mg/l in Pygmy males and females, the gender difference 
being significant in Pygmies (p = 0.024). In Pyg mies 41% and 52% of the males and females, respectively, had 
Lp(a) levels above 300 mg/l, compared with 47% and 55% in Bantus. Overall, Lp(a) 1 evels did not significantly 
differ between Pygmies and Bantus, and did not correlate with age, body mass index (BMI), systolic and diastolic 
blood pressure. Compared with healthy Asian and Caucasian population samples, age- and BMI-adjusted geomet- 
ric Lp(a) means were 2.3- to 5.0.fold high er in Pygmy and Bantu males, and 2.9- to 3.6-fold higher in Pygmy 
and Bantu females (e 5 0.05). A cross the population samples studied ethnicity predicted 12% and 17% of 
serum Lp(a) variance in males and females, respectively. J CLIN EPI~EMIOL 50;9:1045-1053, 1997. 0 1997 Elsevier 
Science Inc. 
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INTRODUCTION 
Lipoprotein(a) (Lp(a)) is a cholesterol-rich complex lipo- 
protein macromolecule, consisting of a low density lipopro- 
tein (LDL)-like particle attached by a disulfide bond to a 
unique glycoprotein, i.e., apolipoprotein(a) (ape(a)) [l]. 
APO(~) is unique because of its structural analogy with plas- 
minogen [2], and its size and functional polymorphism [3,4]. 
Most studies reported that serum Lp(a) levels are mainly 
genetically determined-variation at the ape(a) locus con- 
tributing to this heritability-and are hardly influenced by 
lifestyle, diet, or drugs [l&9]. On the other hand, a few 
studies have shown that the serum Lp(a) level is correlated 
with other variables, such as age [lo-121, sex [II], smoking 
[lo], blood pressure [13], waist-to-hip ratio [lo], impaired 
glucose tolerance [14-161, proteinuria [17], fibrinogen lev- 
els [13,18,19], and use of medication [20,21]. 
So far, and despite the fact that Lp(a) had an attraction 
upon researchers like a “femme fatale,” its physiological 
function is, 34 years after its discovery, still not unraveled. 
From experimental observations it is hypothesized that the 
cholesterol-rich Lp(a) lipoprotein particle probably exports 
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cholesterol out of the liver providing a continuous periph- 
eral supply of such Lp(a)-cholesterol, which is independent 
from diet and other factors and which is reflected by the 
highly stable Lp( a) concentration over long-time periods 
[22]. The most likely targets of Lp(a)-cholesterol are endo- 
crine organs with high steroid hormone production. More 
is known about its pathophysiogical role. First, numerous 
epidemiological and clinical studies, mainly in Caucasians, 
demonstrated that Lp( a) was an independent risk factor for 
coronary heart disease (CHD) [6,23], stroke [24], and pre- 
clinical atherosclerosis [25]. Second, Rath et al. [26] demon- 
strated Lp(a) depositions in the vessel wall of grafted arter- 
ies of coronary bypass patients, and found an association 
with serum Lp(a) levels. Third, it is postulated that elevated 
Lp(a) levels might interfere with fibrinolysis, due to its 
structural analogy with plasminogen [27,28]. Therefore, an 
elevated Lp( a) level is considered to be a risk factor for both 
atherogenesis and thrombogenesis, at least in Caucasians 
[1,6,231. 
Lipoprotein(a) is an inherited CHD risk factor which, 
to our knowledge, has not been investigated in Aboriginal 
African Pygmies yet [1,6]. Besides, knowledge of the genetic 
susceptibility of traditional populations may be valuable in 
order to anticipate future cardiovascular risks, especially if 
these populations would move from traditional lifestyles to 
more sedentary lifestyles [29-3 11. After all, considerable ex- 
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cess of coronary heart disease mortality and greatly in- 
creased prevalence of type 2 diabetes mellitus have been 
reported among expatriate “Westernized” Asian communi- 
ties [29,30] as well as in Aborigines from Western Austra- 
lian in transition to urbanization and Westernization [31]. 
As only a few hunter-gatherer populations remain through- 
out the World, African Pygmies being one of them [32- 
34], and as urbanization may occur in the future, it was de- 
cided to investigate the genetic susceptibility, i.e., serum 
Lp(a) levels, and lifestyle factors of traditional African Ab- 
original Pygmy samples from South-West Cameroon, com- 
pared with Bantu samples from the same region. Because of 
the lack of international Lp(a) standardization [35], and to 
enable relative comparability across populations, serum 
Lp(a) levels in Pygmies and Bantus were compared with 
those of Caucasian and Asian population samples. 
The objectives of this cross-sectional study were, first, 
to provide descriptive data upon serum Lp(a) levels in 
population-based samples of apparently healthy African 
Aboriginal Pygmies and neighboring Bantus, and to de- 
scribe its relationships to other cardiovascular risk factors. 
Second, to compare serum Lp( a) concentrations in African 
Pygmies and Bantus to those in randomized Belgian, Hun- 
garian, and Philippine population samples, displaying vary- 
ing serum cholesterol levels and prevalences of CHD. Fi- 
nally, to compare serum Lp(a) and serum cholesterol levels 
in Pygmies and Bantus with those in healthy and diseased 
Caucasians with overt CHD, respectively. 
MATERIALS AND METHODS 
Study Pofiulations 
This study was part of a wider survey of health in Pygmy 
and Bantu populations in Cameroon, and was carried out 
in January through February 1994, and in May through June 
1994 [33,34]. Non-fasting sera from Bantus and aboriginal 
Pygmies living in South-West Cameroon were obtained as 
described by Kesteloot et al. [33,34]. Pygmies examined live 
in the tropical forests 3” to 4” north of the Equator in small 
communities of 60 to 100 individuals, including children. 
Two distinct Pygmy populations were investigated: One in 
the Mecasse region in the Dja reservation, consisting of 
three distinct communities spreaded out over a 30-km dis- 
tance. The second Pygmy population was living in the re- 
gion of Lolodorf, at a distance of about 80 km. The partici- 
pation rate was estimated to be about 100% in three of the 
four Pygmy communities, whereas it was only 50% in the 
fourth Pygmy community due to a conflict of authority of 
part of the community to the tribal chief. Besides, three 
communities of neighboring Bantus were examined: one 
living in close contact with the Pygmies in the Mecasse 
region, one living in the Lolodorf region, and a separate 
community living in the village of Bengbis. In the Bantu 
population participation was essentially on a first-come, 
first-served basis due to time and blood sample collecting 
material restraints. Many more Bantus volunteered to par- 
ticipate but could not be accommodated. Consequently, it 
was impossible to examine a random sample of the popula- 
tion. 
The Pygmies studied are pure hunter-gatherers, whereas 
the Bantus are agriculturers cultivating corn, maniac, and 
plantain. Since Pygmies do not know their age, the latter 
was estimated with the help of a Bantu teacher, by referral 
to important past events. After specimen collection and 
clot separation with a hand centrifuge, sera were frozen 
within eight hours and stored for maximum one month at 
-2O”C, i.e., during the expedition period in Cameroon. 
Thereafter sera were shipped to Belgium and the Nether- 
lands, stored at -7O”C, and analyzed for serum Lp(a) within 
8 months after sample collection. 
Serum Lp(a) levels in Pygmies and Bantus were compared 
with fasting serum Lp(a) levels in Caucasian and Asian pop- 
ulation samples (Belgians, n = 905; Hungarians, n = 400, 
and Philippines, n = 195). All Caucasian and Asian speci- 
mens investigated were from unrelated, apparently healthy, 
and randomly selected subjects. Firstly, Belgian sera were 
obtained from age- and sex-matched 20- to 39-year-old em- 
ployees from each Belgian province. Recruitment was done 
in the context of a cross-sectional study investigating the 
contribution of environmental and genetically determined 
cardiovascular risk factors to regional serum cholesterol and 
cardiovascular mortality differences in Belgium (manuscript 
in preparation). Hitherto, employees of different socioeco- 
nomic status were invited to participate in this study, prior 
to a scheduled medical check-up. Previous randomization 
and subsequent invitation, and medical check-up were con- 
ducted by the Flemish IDEWE and the Wallonian CeSI, 
two “Centres de Services Interenterprises-Mtdecine du 
Travail”. Informed consent was obtained from all partici- 
pants. Individual questionnaires were distributed during the 
medical check-up; volunteers were invited to fill in their 
identity, home address, nationality, and to indicate their 
smoking, drinking, dietary and lifestyle habits, education 
and profession, use of hormonal contraception, consump- 
tion of lipid lowering or other medication, and so forth. The 
filled-in questionnaire was checked by the physician who 
did the medical check-up, and completed if necessary. In 
addition, height and weight, as well as blood pressure were 
measured by the physician. As the Belgian study group is 
well documented, it was used as a reference population sam- 
ple in this comparative Lp(a) study. Randomized Hungarian 
samples were obtained via the National Institute of Food 
Hygiene and Nutrition, Budapest, Hungary [36], and were 
from adults living in Budapest, and in three different Hun- 
garian regions, i.e., FejCr, BCk&, Kom&om-Esztergom. Phil- 
ippine sera were from free-living individuals on Cebu Island 
and were randomized and obtained via the Philippine Heart 
Center in Quezon City. 
Sera from diseased Caucasians were from unrelated Bel- 
gian male patients who underwent elective coronary artery 
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bypass grafting (CABG) (n = 100) as described previously 
[37], or presented with an acute myocardial infarction (n = 
50) as diagnosed by WHO criteria. In the diseased group, 
serum Lp(a) was determined the day before bypass in the 
CABG patient group, and within 6 hours after onset of 
chest pain in the AM1 patient group. All CABG and AM1 
patients included were free of insulin-dependent diabetes, 
renal insufficiency, cerebrovascular accidents, and liver dis- 
ease. Notable is that in the CABG study group, only pa- 
tients with preoperative serum cholesterol values between 
4.66 and 7.24 mmol/l were included [37]. These highly se- 
lected, diseased Caucasian males were included to enable 
comparison of serum Lp(a) va 1 ues in free-living Pygmies and 
Bantus and in healthy Caucasians to those in diseased Cau- 
casians, using the same Lp(a) methodology. 
Laboratory Methods 
Serum Lp(a) was determined using an anti-ape(a) poly- 
clonal capture ELISA from Biopool (TintElize lipopro- 
tein(a), Cat. No. 610220; Biopool AB, Umea, Sweden). 
The capture polyclonal anti-apo( a) antibody does not cross- 
react with plasminogen up to 1000 mg/l. Lp(a) determina- 
tions in all population samples were performed using the 
TintElize Biopool kit, the assay being calibrated to total 
Lp(a) mass. Considering the lability of the Lp(a) lipopro- 
tein particle [35], a maximum serum storage time of one year 
at - 70°C was respected. At our experimental conditions, it 
was documented by means of frozen human serum pools that 
storage did not affect Lp(a) levels up to two years. 
Cholesterol was determined enzymatically using CHOD- 
PAP reagents. Lipid analyses in the Belgian and Philippine 
population samples were performed at the University Hospi- 
tal Leuven, Belgium, while all other determinations were 
performed at the Lipid Reference Laboratory of the Univer- 
sity Hospital Rotterdam, The Netherlands. The Lipid Refer- 
ence Laboratory (LRL) Rotterdam maintains total choles- 
terol standardization through the Lipid Standardization 
Panel of the Centers for Disease Control (CDC)-National 
Heart Lung and Blood Institute, Atlanta, Georgia. The LRL 
Rotterdam is also a permanent member of the Cholesterol 
Reference Method Laboratory Network (CRMLN) estab- 
lished and coordinated by CDC [38]. The cholesterol values 
determined in the Leuven University Hospital were also 
found to be traceable to the Abell-Kendall reference 
method: in subsets of the samples it was documented that 
the mean average cholesterol bias was in accordance with 
current NCEP performance guidelines (bias 5 3% versus 
the Abell-Kendall reference method) [39]. 
Statistical Methods 
Basic statistical analysis, analysis of variance (ANOVA), 
and Pearson correlation analyses were performed using the 
SPSS/PC+ package (version 5.0.2). Lp(a) and cholesterol 
data were logarithmically (natural) transformed in all popu- 
lation samples, and geometric means were calculated. Gen- 
der differences within populations were evaluated using Stu- 
dent’s t-test. Lp(a) differences among population samples 
were evaluated by one-way ANOVA in either gender. The 
multiple range test of Student-Newman-Keuls was used for 
multiple-comparison of sample means. Age and body mass 
index (BMI)-adjustments of geometric Lp(a) and choles- 
terol means were performed by means of multiple linear re- 
gression analysis (MLR). BMI was defined as weight (in kg)/ 
height’ (in m*). On the aggregated population level a 
weighted least squares MLR analysis was performed to in- 
vestigate whether mean BMI and mean age could predict 
male and female mean serum cholesterol and Lp(a) levels 
across populations, respectively. A statistical significance 
level of cx = 0.05 was adopted. 
RESULTS 
Table 1 displays mean (&SD) age, BMI, and cholesterol per 
gender for the population samples under study. Significant 
age, BMI and cholesterol differences existed among all five 
population samples (ANOVA, p < 0.0001). 
Table 2 presents the unadjusted serum Lp(a) levels in 
African Pygmies and Bantus, compared with Caucasian and 
Asian population samples. Geometric mean Lp(a) levels 
were 274 and 289 mg/l, respectively, in Bantu males (n = 
93) and females (n = 115), and 220 and 299 mg/l in Pygmy 
males (n = 63) and females (n = 83). The gender difference 
was significant in Pygmies (Q = 0.024) and not in Bantus. 
Likewise, Philippine females had higher Lp(a) values than 
males (p = 0.001). Lp(a) frequency distributions in Pygmy 
and Bantu were less skewed to the low concentration end, 
compared to Caucasian and Asian distributions (data not 
shown). In Pygmy males and females, respectively, 4 1% and 
52% of the participants had Lp(a) levels above 300 mg/l, 
compared with 47% and 55% of the Bantus. Serum Lp(a) 
levels did not significantly differ between Pygmies and Ban- 
tus. Multiple-comparison of LnLp( a) means demonstrated 
that Lp(a) levels in Pygmies and Bantus were in either gen- 
der significantly higher compared with those measured in 
any other population sample (SNK-test; D 5 0.05). 
Overall upper reference ranges for men and women com- 
bined, defined as 75th percentiles, were lowest in Asians 
(162 mg/l), intermediate in Caucasians (204 mg/l), and 
highest in African Pygmies and Bantus (479 mg/l). The 
75th percentile in the diseased Caucasian group was 349 
mg/L (data not shown). 
Lp(a) levels in Bantu males and females, and in Pygmy 
females were found to correlate with total cholesterol, LDL- 
cholesterol (LDL-c), and apolipoprotein B (apo B) but not 
with age, BMI, systolic and diastolic blood pressure, HDL- 
cholesterol, and apolipoprotein A-I (Table 3). Serum cho- 
lesterol was associated with age in Bantu males (r = 0.25; 
p = 0.02), while borderline significant in Pygmy males 
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TABLE 1. Age, body mass index, and serum cholesterol levels in African Pygmies and 
Bantus, stratified by sex, compared with Asian and Caucasian population samples 
Age BMI Cholesterol 
(years) (kg/m’) (mmol/l) 
Population n Mean SD Mean SD Mean SD 
Men 
Apparently healthy population samples 
AfricaIns 
Pygmies 63 33.8 16.6 20.0 2.4 2.885 0.693 
Bantus 93 41.2 20.0 20.6 2.6 3.119 0.725 
Caucasians 
Belgians 413 31.4 5.2 24.1 3.3 5.279 1.073 
H ungarians 200 42.2 12.3 26.8 3.9 6.017 1.223 
Asians 
Philippines 96 43.7 10.7 23.8 3.4 5.301 0.981 
Diseased Caucasians (Belgians) 
CABG patients 100 53.8 4.8 25.8 2.6 5.589 0.891 
AMI patients 50 59.5 11.6 25.5 3.1 5.551 1.025 
Women 
Apparently healthy population samples 
Africans 
Pygmies 83 29.4 15.3 19.9 3.0 3.174 0.673 
Bantus 115 44.8 17.4 20.9 2.9 3.559 0.714 
Caucasians 
Belgians 492 30.2 5.3 22.2 3.1 5.117 0.971 
Hungarians 200 40.3 10.5 26.0 5.6 5.702 1.162 
Asians 
Philippines 99 46.9 10.4 23.1 3.9 5.433 1.155 
TABLE 2. Serum lipoprotein(a) levels in African Pygmies and Bantus, stratified by sex, compared with randomly selected 
Caucasian and Asian population samples 
Lipoprotein(a) mass 
(mgll) 
Geometric Percentile >300 mp/L 
Population I1 mean 5 10 25 50 75 90 95 (%) - 
Men 
Apparently healthy population samples 
Africans 
Pygmies 
Bantus 
Caucasians 
Belgians 
Hungarians 
Asians 
Philippines 
Diseased Caucasians (Belgians) 
CABG patients 
AMI patients 
Women 
Apparently healthy population samples 
Africans 
Pygmies 
Bantus 
Caucasians 
Belgians 
H ungarians 
Asians 
Philippines 
63 220” 37 62 
93 274 50 78 
413 70 6 10 
200 85 11 17 
96 52” 9 12 
100 130 10 17 
50 113 14 35 
83 299 86 
115 289 58 
492 67 7 
200 86 12 
99 86 18 
141 234 424 530 758 41 
180 259 525 826 972 47 
30 71 216 455 566 20 
39 73 249 464 645 21 
24 52 127 269 323 7 
61 135 409 576 824 34 
58 97 249 599 651 19 
125 192 331 557 669 928 52 
74 179 317 538 888 1111 55 
11 
19 
21 
27 67 186 411 553 16 
34 74 237 566 776 22 
44 88 176 294 399 9 
“p 5 0.05 for gender differences within population samples (Student’s t-test). 
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TABLE 3. Pearson correlations of LnLp(a) with anthropoe 
metric data and serum lipids in African Pygmies and Bantus, 
with respect to gender 
Bantu Pygmy 
Males Females Males Females 
Variable n = 92 n= 113 n = 63 n = 83 
Age 
BMI 
SBP 
DBP 
IHeart rate 
Apo A-I 
HDL-cholesterol 
Apo R 
LDL-cholesterol 
Cholesterol 
Netto triglycerides 
-0.06 0.06 -0.10 0.16 
0.12 -0.15 0.06 0.10 
-0.07 -0.09 -0.01 0.09 
-0.06 0.15 -0.04 0.02 
-0.03 -0.04 0.13 0.08 
0.11 PO.00 -0.00 -0.05 
0.06 -0.02 -0.04 0.12 
0.38’ 0.31” 0.19 0.31” 
0.50’ 0.39’ 0.03 0.35h 
0.35’ 0.28” 0.06 0.28” 
~0.26” -0.02 0.13 -0.13 
“p < 0.05. 
“p < 0.01. 
‘1, < 0.001. 
(r = 0.22; p = 0.08). In contrast, serum cholesterol was 
not significantly associated with age in Pygmy respectively 
Bantu females (data not shown). 
Table 4 depicts age- and BMI-adjusted geometric Lp(a) 
and cholesterol means per gender for the population sam- 
ples studied. P-values are given, versus the Belgian popula- 
tion sample, the latter being the reference population sam- 
ple in the MLR analysis. Pygmy and Bantu concentrations 
differed significantly from Belgian levels (p < 0.000 1 ), Pyg- 
mies and Bantus having the lowest serum cholesterol, and 
the highest serum Lp(a) levels among the population sam- 
ples studied. Philippine males had Lp(a) levels that were 
significantly lower compared with those in Belgian males, 
while Hungarian females displayed significantly higher 
Lp(a) levels compared to Belgian females. Both Hungarian 
males and females had significantly higher cholesterol val- 
ues compared to Belgians. Age- and BMI-adjusted geomet- 
ric Lp(a) means were 2.8-and 4.3-fold higher in male respec- 
tively female Pygmies compared to Belgian males and 
females, and 3.5, and 3.9-fold higher in male and female 
Bantus (p < 0.0001). Finally, age- and BMI-adjusted serum 
Lp(a) levels in diseased Belgian mzales were significantly 
higher than in apparently healthy Belgian males: 131 mg/ 
1 in CABG patients and 114 mg/l in AM1 patients, com- 
pared with 72 mg/l in healthy male participants. 
MLR analysis pointed out that BMI, age, and ethnicity 
explained 12% and 17% of serum Lp(a) variance in males 
and females, respectively, compared with 60% and 51% of 
serum cholesterol variance. BMI and age alone explained 
maximum 3% of Lp(a) variance. After adjusting for eth- 
nicity BMI remained a borderline significant predictor in 
either gender (BMI in males: p = 0.08; BMI in females: 
p = 0.09), in contrast with age. Moreover, Table 5 demon- 
TABLE 4. Age- and BMI-adjusted geometric mean values of serum lipoprotein(a) and serum cholesterol in African Pygmies 
and Bantus, stratified by sex, compared with randomly selected Caucasian and Asian population samples 
p-Value vs. pValue vs. 
Cholesterol Belgians of the Lipoprotein(a) Belgians of the 
Population n (mmolll) same gender (mgll) same gender 
Men 
Apparently healthy population samples 
Africans 
Pygmies 63 3.017 <0.0001 204 <0.0001 
Bantus 93 3.159 <0.0001 253 <0.0001 
Caucasians 
Belgians 413 5.336 72 
Hungarians 200 5.659 0.0012 88 NS 
Asians 
Philippines 96 5.159 NS 51 0.0243 
Diseased Caucasians (Belgians) 
CABG patients 100 5.159 NS 131 0.0003 
AM1 patients 50 4.895 0.0164 114 0.0545 
Women 
Apparently healthy population samples 
Africans 
Pygmies 83 3.241 <0.0001 289 <0.0001 
Bantus 115 3.445 <0.0001 264 <0.0001 
Caucasians 
Belgians 492 5.104 67 
Hungarians 200 5.296 0.036 90 0.0129 
Asians 
Philippines 99 5.111 NS 81 NS 
Abbreviation: NS = nor signikmt. 
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TABLE 5. Weighted least squares multiple linear regression analysis in aggregated Cauca- 
sian, Asian, and African population samples (n = 5), stratified by sex, with mean serum 
lipoprotein(a) and mean serum cholesterol as dependent variables, and with mean age and 
mean BMI as independent variables 
Dependent variable Predictors Coefficient S.E. L, Value 
Men 
Mean Ln Lp(a) 
(Ln Ins/l) 
Mean Ln cholesterol 
(Ln mmol/l) 
Women 
Mean Ln Lp(a) 
(Ln mg/l) 
Mean Ln cholesterol 
(Ln mmol/l) 
Men and women 
Mean Ln Lp(a) 
(Ln msil) 
Mean BMI (kg/m’) -0.1873 
Mean age (year) 0.0316 
Constant 7.8378 
Mean BMI (kg/m*) 0.1148 
Mean age (year) -0.0085 
Constant -0.8720 
Mean BMI (kg/m’) -0.2071 
Mean age (year) 0.0510 
Constant 7.4687 
Mean BMI (kg/m’) 0.0885 
Mean age (year) -0.0087 
Constant -0.1421 
Sex (female) -0.1272 
Mean BMI (kg/m’) -0.1954 
Mean age (year) 0.0435 
Constant 7.5961 
0.1174 NS 
0.0447 NS 
2.9511 NS 
0.0250 0.04 
0.0095 NS 
0.6284 NS 
0.1610 NS 
0.0445 NS 
3.4060 NS 
0.0445 NS 
0.0123 NS 
0.942 1 NS 
0.3170 NS 
0.0812 0.05 
0.0258 NS 
1.9049 0.007 
Abbreviation: NS = not significant 
strates that at the aggregated level, i.e., across the popula- ied. Notwithstanding the fact that the Bantu population 
tion samples studied, overall mean BMI was negatively cor- sample was not randomly gathered, it reflects the Bantu cul- 
related with overall mean Lp(a) levels (p = 0.05) if men tures from the Mecasse and the Lolodorf region, and the 
and women were grouped. city of Bengbis. 
DISCUSSION 
The Pygmies studied are pure hunter-gatherers and are the 
Aborigines in Africa south of the Sahara. They were over- 
run by the Bantu who, from 1200-1400 A.D. gradually 
spread from the upper Nile Valley and the region of Lake 
Chad southward and westward over the continent [32]. Up 
to now, Pygmies live in isolated groups among the Bantu 
and along the Equator. As described by Kesteloot et al. 
[33,40], the characteristic diminutive Pygmy stature to- 
gether with the consistent Pygmy body measurements, life- 
style factors and serum lipid levels compared to previous 
reports [32], are a reflection of the homogeneity of the 
Pygmy race and of the fact that a representative sample was 
taken. The Pygmy sample investigated, though partly con- 
sisting of related individuals as children were included, was 
derived from four different communities living in and 
nearby the Dja reservation in South-West Cameroon. Due 
to the high participation rate the Pygmy sample is a good 
representation of the current Pygmy cohabitation in those 
specific regions. However, the representativeness for the to- 
tal African Pygmy population is unknown. The same holds 
for the Bantu sample investigated: volunteers from three 
neighboring communities, mainly entered on a first-come, 
first-served basis and partly containing relatives, were stud- 
In this study, we focused upon the genetically determined 
Lp(a) lipoprotein risk factor, in relation to the modifiable 
serum cholesterol risk factor and to ethnicity. Notable fea- 
tures of our study are the exceptionally low mean serum 
cholesterol levels in Pygmies, the absent or minor choles- 
terol increase with estimated age, as well as the two- to five- 
fold higher mean Lp(a) levels (Tables 2 and 4) compared 
with Asians and Caucasians. Bantus had the same mean 
Lp(a) level as Pygmies, while age- and BMI-adjusted serum 
cholesterol levels were approximately 5% higher both in 
males and females, and increased significantly with age in 
Bantu males. From Table 2 it can be seen that 41-55% of 
Pygmies and Bantus had serum Lp(a) levels above 300 mg/ 
1, the universally accepted upper reference limit in Cauca- 
sians. As presence of CHD is very unlikely in African Pyg- 
mies [32] and Bantus, the high serum Lp( a) concentrations 
samples must either be counteracted by other factors, or be 
in itself an insufficient cause for developing atherosclerosis. 
Consequently, we agree with others [41,42] that for identi- 
fying subjects at increased risk of coronary heart disease, 
ethnicity-related cutoff values, based on 75th percentiles, 
should be used for Lp(a). 
Using MLR serum Lp( a) variances could be explained up 
to 12% and 17% in males and females, respectively, across 
the healthy population samples studied, and were predicted 
exclusively by ethnicity and barely by age or BMI. However, 
Seruln LP(a) Levels in African Aboriginal Pygmies and Bantus 
at the aggregated level, mean BMI was negatively correlated 
with mean Lp(a) if men and women were combined, while 
no significant correlation was observed with mean age (Ta- 
ble 5). Finally, the tight univariate correlations demon- 
strated with total cholesterol, apo B and LDL-c in Pygmies 
and Bantus could be explained by the high relative percent- 
age of Lp(a)-cholesterol and Lp(a)-apo B compared with 
Asians and Caucasians (Table 3). 
The large differences in serum Lp(a) between African 
Pygmies and Bantus compared with Asians [43,44] and Cau- 
casians [lo-13,41,43,45,46], and the absence of association 
with many other variables except serum lipids, are consis- 
tent with previous reports that state that Lp(a) levels are 
largely genetically determined [ 1,5,6]. Also, the height and 
distribution of the serum Lp(a) levels in Pygmies and Bantus 
seem to be comparable or even higher than those described 
in Nigerians [43], Congolese [47], Sudanese [48] and Ameri- 
can blacks [19,25,49-531. The high Lp(a) levels in blacks, 
without corresponding high prevalence of CHD, suggest 
that race and gender differences in ape(a) phenotypes, he- 
mostatic activity, or other unrelated factors may contribute 
to this paradox. However, from twin studies it became clear 
that neither behavioral or environmental correlates, nor 
variation in the ape(a) size phenotype appeared to explain 
the higher mean Lp(a) levels among blacks compared to 
whites [7]. Rather these findings corroborate the hypothesis 
that Lp(a) is a continuous supplier of liver cholesterol to 
peripheral endocrine organs independent of triglycerides or 
dietary cholesterol intake, being preferentially preserved 
during human evolution in black African populations of 
which the food supply was not as regulated as that of Cauca- 
sian and Asian populations. In contrast, in civilized human 
populations, Lp(a) may have lost its phylogenetical impor- 
tance since other cholesterol-rich lipoproteins, notably 
LDL, are highly abundant. Moreover, potential adverse ef- 
fects of high Lp( a) levels should become overt especially in 
these civilized populations. This may be in line with the 
significant shift-to-the-right of the Lp(a) distributions (Ta- 
ble 2) and of the geometric means (Table 4) in Caucasian 
CABG and AM1 patients, respectively, compared with 
healthy Caucasians, notwithstanding similar (CABG 
group) or even lower (AMI group) mean cholesterol levels 
in the diseased Caucasian groups (Table 4). The shift-to- 
the right is also in accordance with the findings of numerous 
other authors [6,22]. Although CHD is a multifactorial dis- 
ease, the 1.6. and 1.8-fold higher, respectively, adjusted 
Lp( a) means in diseased compared with healthy Caucasians 
may be elements aggravating the atherosclerosis risk of 
these subjects and contributing to their disease. In contrast, 
the high Lp(a) levels in Pygmies and Bantus without con- 
comitant high prevalence of CHD are difficult to under- 
stand. Yet, according to Maher et al. 1541 Lp(a) is especially 
atherogenic in combination with high (LDL-) cholesterol 
levels or other acquired risk factors, e.g., due to Westerniza- 
tion [29-311, that can nurture Lp(a) into a more potent 
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risk factor. To draw firm conclusions regarding the Lp(a) 
pathogenicity in Pygmies, Bantus, and other population 
samples prospective studies are warranted that document 
Lp(a) atherogenicity and its determinants in different popu- 
lations. 
Major strengths of this study are the fact that serum Lp( a) 
levels were obtained using one and the same method in all 
population samples, and were determined in frozen sera that 
were adequately stored for less than one year. Therefore, 
storage time and temperature did not confound the mea- 
sured Lp(a) results [35]. Limitations of this study are related 
to the cross-sectional study design and the relatively small 
sample sizes. Moreover, Pygmy and Bantu samples were not 
completely randomized, in contrast with the Asian and 
Caucasian samples. Consequently, extrapolation of these 
data to whole populations should be done with caution. 
Also, the diseased Caucasians represent two strongly se- 
lected groups that were, with the exception of BMI and age, 
not matched or adjusted for other cardiovascular risk 
factors. 
We conclude that African Aboriginal Pygmies and Ban- 
tus have serum Lp(a) levels that are comparable, with ad- 
justed Lp(a) means being up to fivefold higher compared 
with Asian and Caucasian means. In contrast, adjusted se- 
rum cholesterol means were 0.57- to 0.67-fold the Cauca- 
sian and Asian means. In the light of the virtual absence 
of CHD in Aboriginal African Pygmies and Bantus, high 
serum Lp(a) levels do not seem to be very deleterious in 
these population samples. Consequently, ethnicity-related 
upper reference values should be used for Lp(a). Also, longi- 
tudinal studies are warranted to determine the pathogenic- 
ity of Lp(a) in different populations with variable interrela- 
tionships between nature and nurture. 
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